ANVISA registration 80146502403Valid until May 26, 2035HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS
ANVISA Registration Number: 80146502403ABBOTT LABORATORIOS DO BRASIL LTDAABBOTT MOLECULAR INCRisk Class IV
Device names
- Technical name
- HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS
- Risk class
- Class IV
PT: HERPES VÍRUS (HHV 5) - CITOMEGALOVÍRUS
Registration details
- Registration Number
- 80146502403
- Process Number
- 25351437817202466
- CNPJ
- 56998701000116
Company information
- Registration Holder
- ABBOTT LABORATORIOS DO BRASIL LTDA
- Manufacturer
- ABBOTT MOLECULAR INC
- Manufacturing Country
- United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
- Publication Date
- May 26, 2025
- Validity
- 26/05/2035
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for HERPES VIRUS (HHV 5) - CYTOMEGALOVIRUS in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 80146502403 and manufactured by ABBOTT MOLECULAR INC. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until May 26, 2035.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.